Hrzenjak, Andelko <br/><br/>
Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo.  [electronic resource] 

 -  Molecular cancer  Mar 2010 
 - 49 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4598 
<br/><br/><label>Standard No.: </label>10.1186/1476-4598-9-49  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p21--metabolism<br/>Female<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histone Deacetylases--metabolism<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Immunohistochemistry<br/>Ki-67 Antigen--metabolism<br/>Male<br/>Mice<br/>Mice, Nude<br/>Middle Aged<br/>Sarcoma--enzymology<br/>Tumor Stem Cell Assay<br/>Uterine Cervical Neoplasms--enzymology<br/>Vorinostat<br/>Xenograft Model Antitumor Assays